tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:AVCT Stock Latest News

Avacta to Spotlight Tumor-Targeted Oncology Platform at TD Cowen Conference
Company AnnouncementsAvacta to Spotlight Tumor-Targeted Oncology Platform at TD Cowen Conference
6d ago
Avacta names Francis Wilson Chief Scientific Officer to drive pre|CISION® oncology platform
PremiumCompany Announcements
Avacta names Francis Wilson Chief Scientific Officer to drive pre|CISION® oncology platform
15d ago
Avacta Lifts Dosing Cap and Sets Path to Efficacy Trials for Faridoxorubicin
PremiumCompany Announcements
Avacta Lifts Dosing Cap and Sets Path to Efficacy Trials for Faridoxorubicin
21d ago
Avacta Wins FDA IND Clearance for Second pre|CISION® Cancer Drug AVA6103
PremiumCompany Announcements
Avacta Wins FDA IND Clearance for Second pre|CISION® Cancer Drug AVA6103
1M ago
Avacta Advances Tumor-Targeted Oncology Pipeline and Extends Cash Runway Into Q3 2026
PremiumCompany Announcements
Avacta Advances Tumor-Targeted Oncology Pipeline and Extends Cash Runway Into Q3 2026
1M ago
Avacta Names Strand Hanson as Nominated Adviser and Updates Share Capital and Governance Disclosures
PremiumCompany AnnouncementsAvacta Names Strand Hanson as Nominated Adviser and Updates Share Capital and Governance Disclosures
1M ago
Avacta Unveils Promising Data for Tumor-Targeted Cancer Therapy FAP-Exd
Premium
Company Announcements
Avacta Unveils Promising Data for Tumor-Targeted Cancer Therapy FAP-Exd
2M ago
Avacta’s Faridoxorubicin Shows Promising Results in Salivary Gland Cancer Trials
Premium
Company Announcements
Avacta’s Faridoxorubicin Shows Promising Results in Salivary Gland Cancer Trials
2M ago
Avacta Group Announces Preliminary Data in Salivary Gland Cancer Trial
PremiumCompany Announcements
Avacta Group Announces Preliminary Data in Salivary Gland Cancer Trial
3M ago
Avacta Unveils Innovative Dual Payload Cancer Therapy
PremiumCompany Announcements
Avacta Unveils Innovative Dual Payload Cancer Therapy
4M ago
Avacta to Present Innovative Oncology Platform Data to Investors
PremiumCompany Announcements
Avacta to Present Innovative Oncology Platform Data to Investors
4M ago
Avacta Group Raises £16 Million to Advance Oncology Programs
PremiumCompany Announcements
Avacta Group Raises £16 Million to Advance Oncology Programs
4M ago
Avacta’s Faridoxorubicin Shows Promising Phase 1a Results in Cancer Treatment
PremiumCompany AnnouncementsAvacta’s Faridoxorubicin Shows Promising Phase 1a Results in Cancer Treatment
4M ago
Avacta Unveils Dual-Payload Oncology Innovation
Premium
Company Announcements
Avacta Unveils Dual-Payload Oncology Innovation
4M ago
Avacta Group’s Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Avacta Group’s Earnings Call: Progress Amid Challenges
5M ago
Avacta Group Reports Promising Interim Results and Strengthened Financial Position
PremiumCompany Announcements
Avacta Group Reports Promising Interim Results and Strengthened Financial Position
5M ago
Avacta Group Announces Interim Results and ESMO Congress Update
PremiumCompany Announcements
Avacta Group Announces Interim Results and ESMO Congress Update
5M ago
Avacta’s pre|CISION® Platform Shortlisted for AIM Technology of the Year Award
PremiumCompany Announcements
Avacta’s pre|CISION® Platform Shortlisted for AIM Technology of the Year Award
6M ago
Avacta Completes Sale of Coris Bioconcept to 3B BlackBio Dx
PremiumCompany Announcements
Avacta Completes Sale of Coris Bioconcept to 3B BlackBio Dx
6M ago
Avacta Group Secures £3.25 Million Fundraise and Amends Convertible Bond Terms
PremiumCompany AnnouncementsAvacta Group Secures £3.25 Million Fundraise and Amends Convertible Bond Terms
6M ago
Avacta to Present Updated FAP-Dox Trial Data at ESMO Congress
Premium
Company Announcements
Avacta to Present Updated FAP-Dox Trial Data at ESMO Congress
7M ago
Avacta Group Completes Transition to Pure-Play Therapeutics with Sale of Coris Bioconcept
Premium
Company Announcements
Avacta Group Completes Transition to Pure-Play Therapeutics with Sale of Coris Bioconcept
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >